table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2030)
1.4.2 East Asia Market States and Outlook (2023-2030)
1.4.3 Europe Market States and Outlook (2023-2030)
1.4.4 South Asia Market States and Outlook (2023-2030)
1.4.5 Southeast Asia Market States and Outlook (2023-2030)
1.4.6 Middle East Market States and Outlook (2023-2030)
1.4.7 Africa Market States and Outlook (2023-2030)
1.4.8 Oceania Market States and Outlook (2023-2030)
1.4.9 South America Market States and Outlook (2023-2030)
1.5 Global Targeted Drugs for NSCLC Market Size Analysis from 2023 to 2030
1.5.1 Global Targeted Drugs for NSCLC Market Size Analysis from 2023 to 2030 by Consumption Volume
1.5.2 Global Targeted Drugs for NSCLC Market Size Analysis from 2023 to 2030 by Value
1.5.3 Global Targeted Drugs for NSCLC Price Trends Analysis from 2023 to 2030
1.6 COVID-19 Outbreak: Targeted Drugs for NSCLC Industry Impact
Chapter 2 Global Targeted Drugs for NSCLC Competition by Types, Applications, and Top Regions and Countries
2.1 Global Targeted Drugs for NSCLC (Volume and Value) by Type
2.1.1 Global Targeted Drugs for NSCLC Consumption and Market Share by Type (2017-2022)
2.1.2 Global Targeted Drugs for NSCLC Revenue and Market Share by Type (2017-2022)
2.2 Global Targeted Drugs for NSCLC (Volume and Value) by Application
2.2.1 Global Targeted Drugs for NSCLC Consumption and Market Share by Application (2017-2022)
2.2.2 Global Targeted Drugs for NSCLC Revenue and Market Share by Application (2017-2022)
2.3 Global Targeted Drugs for NSCLC (Volume and Value) by Regions
2.3.1 Global Targeted Drugs for NSCLC Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Targeted Drugs for NSCLC Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Targeted Drugs for NSCLC Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Targeted Drugs for NSCLC Consumption by Regions (2017-2022)
4.2 North America Targeted Drugs for NSCLC Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Targeted Drugs for NSCLC Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Targeted Drugs for NSCLC Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Targeted Drugs for NSCLC Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Targeted Drugs for NSCLC Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Targeted Drugs for NSCLC Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Targeted Drugs for NSCLC Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Targeted Drugs for NSCLC Sales, Consumption, Export, Import (2017-2022)
4.10 South America Targeted Drugs for NSCLC Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Targeted Drugs for NSCLC Market Analysis
5.1 North America Targeted Drugs for NSCLC Consumption and Value Analysis
5.1.1 North America Targeted Drugs for NSCLC Market Under COVID-19
5.2 North America Targeted Drugs for NSCLC Consumption Volume by Types
5.3 North America Targeted Drugs for NSCLC Consumption Structure by Application
5.4 North America Targeted Drugs for NSCLC Consumption by Top Countries
5.4.1 United States Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
5.4.2 Canada Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
5.4.3 Mexico Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
Chapter 6 East Asia Targeted Drugs for NSCLC Market Analysis
6.1 East Asia Targeted Drugs for NSCLC Consumption and Value Analysis
6.1.1 East Asia Targeted Drugs for NSCLC Market Under COVID-19
6.2 East Asia Targeted Drugs for NSCLC Consumption Volume by Types
6.3 East Asia Targeted Drugs for NSCLC Consumption Structure by Application
6.4 East Asia Targeted Drugs for NSCLC Consumption by Top Countries
6.4.1 China Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
6.4.2 Japan Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
6.4.3 South Korea Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
Chapter 7 Europe Targeted Drugs for NSCLC Market Analysis
7.1 Europe Targeted Drugs for NSCLC Consumption and Value Analysis
7.1.1 Europe Targeted Drugs for NSCLC Market Under COVID-19
7.2 Europe Targeted Drugs for NSCLC Consumption Volume by Types
7.3 Europe Targeted Drugs for NSCLC Consumption Structure by Application
7.4 Europe Targeted Drugs for NSCLC Consumption by Top Countries
7.4.1 Germany Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
7.4.2 UK Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
7.4.3 France Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
7.4.4 Italy Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
7.4.5 Russia Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
7.4.6 Spain Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
7.4.7 Netherlands Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
7.4.8 Switzerland Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
7.4.9 Poland Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
Chapter 8 South Asia Targeted Drugs for NSCLC Market Analysis
8.1 South Asia Targeted Drugs for NSCLC Consumption and Value Analysis
8.1.1 South Asia Targeted Drugs for NSCLC Market Under COVID-19
8.2 South Asia Targeted Drugs for NSCLC Consumption Volume by Types
8.3 South Asia Targeted Drugs for NSCLC Consumption Structure by Application
8.4 South Asia Targeted Drugs for NSCLC Consumption by Top Countries
8.4.1 India Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
8.4.2 Pakistan Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Targeted Drugs for NSCLC Market Analysis
9.1 Southeast Asia Targeted Drugs for NSCLC Consumption and Value Analysis
9.1.1 Southeast Asia Targeted Drugs for NSCLC Market Under COVID-19
9.2 Southeast Asia Targeted Drugs for NSCLC Consumption Volume by Types
9.3 Southeast Asia Targeted Drugs for NSCLC Consumption Structure by Application
9.4 Southeast Asia Targeted Drugs for NSCLC Consumption by Top Countries
9.4.1 Indonesia Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
9.4.2 Thailand Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
9.4.3 Singapore Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
9.4.4 Malaysia Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
9.4.5 Philippines Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
9.4.6 Vietnam Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
9.4.7 Myanmar Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
Chapter 10 Middle East Targeted Drugs for NSCLC Market Analysis
10.1 Middle East Targeted Drugs for NSCLC Consumption and Value Analysis
10.1.1 Middle East Targeted Drugs for NSCLC Market Under COVID-19
10.2 Middle East Targeted Drugs for NSCLC Consumption Volume by Types
10.3 Middle East Targeted Drugs for NSCLC Consumption Structure by Application
10.4 Middle East Targeted Drugs for NSCLC Consumption by Top Countries
10.4.1 Turkey Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
10.4.3 Iran Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
10.4.5 Israel Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
10.4.6 Iraq Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
10.4.7 Qatar Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
10.4.8 Kuwait Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
10.4.9 Oman Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
Chapter 11 Africa Targeted Drugs for NSCLC Market Analysis
11.1 Africa Targeted Drugs for NSCLC Consumption and Value Analysis
11.1.1 Africa Targeted Drugs for NSCLC Market Under COVID-19
11.2 Africa Targeted Drugs for NSCLC Consumption Volume by Types
11.3 Africa Targeted Drugs for NSCLC Consumption Structure by Application
11.4 Africa Targeted Drugs for NSCLC Consumption by Top Countries
11.4.1 Nigeria Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
11.4.2 South Africa Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
11.4.3 Egypt Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
11.4.4 Algeria Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
11.4.5 Morocco Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
Chapter 12 Oceania Targeted Drugs for NSCLC Market Analysis
12.1 Oceania Targeted Drugs for NSCLC Consumption and Value Analysis
12.2 Oceania Targeted Drugs for NSCLC Consumption Volume by Types
12.3 Oceania Targeted Drugs for NSCLC Consumption Structure by Application
12.4 Oceania Targeted Drugs for NSCLC Consumption by Top Countries
12.4.1 Australia Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
12.4.2 New Zealand Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
Chapter 13 South America Targeted Drugs for NSCLC Market Analysis
13.1 South America Targeted Drugs for NSCLC Consumption and Value Analysis
13.1.1 South America Targeted Drugs for NSCLC Market Under COVID-19
13.2 South America Targeted Drugs for NSCLC Consumption Volume by Types
13.3 South America Targeted Drugs for NSCLC Consumption Structure by Application
13.4 South America Targeted Drugs for NSCLC Consumption Volume by Major Countries
13.4.1 Brazil Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
13.4.2 Argentina Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
13.4.3 Columbia Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
13.4.4 Chile Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
13.4.5 Venezuela Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
13.4.6 Peru Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
13.4.8 Ecuador Targeted Drugs for NSCLC Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Targeted Drugs for NSCLC Business
14.1 Allergan
14.1.1 Allergan Company Profile
14.1.2 Allergan Targeted Drugs for NSCLC Product Specification
14.1.3 Allergan Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Amgen
14.2.1 Amgen Company Profile
14.2.2 Amgen Targeted Drugs for NSCLC Product Specification
14.2.3 Amgen Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 ARIAD Pharmaceuticals (Takeda)
14.3.1 ARIAD Pharmaceuticals (Takeda) Company Profile
14.3.2 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Specification
14.3.3 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Beacon Pharma Limited
14.4.1 Beacon Pharma Limited Company Profile
14.4.2 Beacon Pharma Limited Targeted Drugs for NSCLC Product Specification
14.4.3 Beacon Pharma Limited Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 BeiGene
14.5.1 BeiGene Company Profile
14.5.2 BeiGene Targeted Drugs for NSCLC Product Specification
14.5.3 BeiGene Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Biocon
14.6.1 Biocon Company Profile
14.6.2 Biocon Targeted Drugs for NSCLC Product Specification
14.6.3 Biocon Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Boehringer-Ingelheim
14.7.1 Boehringer-Ingelheim Company Profile
14.7.2 Boehringer-Ingelheim Targeted Drugs for NSCLC Product Specification
14.7.3 Boehringer-Ingelheim Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Celgene Corporation
14.8.1 Celgene Corporation Company Profile
14.8.2 Celgene Corporation Targeted Drugs for NSCLC Product Specification
14.8.3 Celgene Corporation Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Drug International Limted
14.9.1 Drug International Limted Company Profile
14.9.2 Drug International Limted Targeted Drugs for NSCLC Product Specification
14.9.3 Drug International Limted Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Fujifilm Kyowa Kirin Biologics
14.10.1 Fujifilm Kyowa Kirin Biologics Company Profile
14.10.2 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Specification
14.10.3 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Genvio Pharma Limited
14.11.1 Genvio Pharma Limited Company Profile
14.11.2 Genvio Pharma Limited Targeted Drugs for NSCLC Product Specification
14.11.3 Genvio Pharma Limited Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Hetero Drugs
14.12.1 Hetero Drugs Company Profile
14.12.2 Hetero Drugs Targeted Drugs for NSCLC Product Specification
14.12.3 Hetero Drugs Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 ImClone Systems ?(Eli Lilly)
14.13.1 ImClone Systems ?(Eli Lilly) Company Profile
14.13.2 ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Product Specification
14.13.3 ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Incepta Pharmaceuticals
14.14.1 Incepta Pharmaceuticals Company Profile
14.14.2 Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Specification
14.14.3 Incepta Pharmaceuticals Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Mylan
14.15.1 Mylan Company Profile
14.15.2 Mylan Targeted Drugs for NSCLC Product Specification
14.15.3 Mylan Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Novartis
14.16.1 Novartis Company Profile
14.16.2 Novartis Targeted Drugs for NSCLC Product Specification
14.16.3 Novartis Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Pfizer
14.17.1 Pfizer Company Profile
14.17.2 Pfizer Targeted Drugs for NSCLC Product Specification
14.17.3 Pfizer Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Reliance Lifesciences
14.18.1 Reliance Lifesciences Company Profile
14.18.2 Reliance Lifesciences Targeted Drugs for NSCLC Product Specification
14.18.3 Reliance Lifesciences Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.19 Roche
14.19.1 Roche Company Profile
14.19.2 Roche Targeted Drugs for NSCLC Product Specification
14.19.3 Roche Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.20 AstraZeneca
14.20.1 AstraZeneca Company Profile
14.20.2 AstraZeneca Targeted Drugs for NSCLC Product Specification
14.20.3 AstraZeneca Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.21 Cipla
14.21.1 Cipla Company Profile
14.21.2 Cipla Targeted Drugs for NSCLC Product Specification
14.21.3 Cipla Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.22 Teva
14.22.1 Teva Company Profile
14.22.2 Teva Targeted Drugs for NSCLC Product Specification
14.22.3 Teva Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.23 OSI Pharmaceuticals
14.23.1 OSI Pharmaceuticals Company Profile
14.23.2 OSI Pharmaceuticals Targeted Drugs for NSCLC Product Specification
14.23.3 OSI Pharmaceuticals Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.24 Glenmark Pharmaceuticals
14.24.1 Glenmark Pharmaceuticals Company Profile
14.24.2 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Specification
14.24.3 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.25 Natco Pharma
14.25.1 Natco Pharma Company Profile
14.25.2 Natco Pharma Targeted Drugs for NSCLC Product Specification
14.25.3 Natco Pharma Targeted Drugs for NSCLC Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Targeted Drugs for NSCLC Market Forecast (2023-2030)
15.1 Global Targeted Drugs for NSCLC Consumption Volume, Revenue and Price Forecast (2023-2030)
15.1.1 Global Targeted Drugs for NSCLC Consumption Volume and Growth Rate Forecast (2023-2030)
15.1.2 Global Targeted Drugs for NSCLC Value and Growth Rate Forecast (2023-2030)
15.2 Global Targeted Drugs for NSCLC Consumption Volume, Value and Growth Rate Forecast by Region (2023-2030)
15.2.1 Global Targeted Drugs for NSCLC Consumption Volume and Growth Rate Forecast by Regions (2023-2030)
15.2.2 Global Targeted Drugs for NSCLC Value and Growth Rate Forecast by Regions (2023-2030)
15.2.3 North America Targeted Drugs for NSCLC Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.4 East Asia Targeted Drugs for NSCLC Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.5 Europe Targeted Drugs for NSCLC Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.6 South Asia Targeted Drugs for NSCLC Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.7 Southeast Asia Targeted Drugs for NSCLC Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.8 Middle East Targeted Drugs for NSCLC Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.9 Africa Targeted Drugs for NSCLC Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.10 Oceania Targeted Drugs for NSCLC Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.11 South America Targeted Drugs for NSCLC Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.3 Global Targeted Drugs for NSCLC Consumption Volume, Revenue and Price Forecast by Type (2023-2030)
15.3.1 Global Targeted Drugs for NSCLC Consumption Forecast by Type (2023-2030)
15.3.2 Global Targeted Drugs for NSCLC Revenue Forecast by Type (2023-2030)
15.3.3 Global Targeted Drugs for NSCLC Price Forecast by Type (2023-2030)
15.4 Global Targeted Drugs for NSCLC Consumption Volume Forecast by Application (2023-2030)
15.5 Targeted Drugs for NSCLC Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
